SCHEMBL27647412

SCHEMBL27647412

O=CNC1CSCN1NC=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADH1B P00325 1/20 0.30
▸ ADH1A P07327 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27693621 0.65 ADH1B (0.38) ADH1BADH1A
SCHEMBL27627179 0.63 — —
SCHEMBL28233826 0.63 — —
SCHEMBL28310282 0.62 — —
SCHEMBL1807302 0.58 — —
SCHEMBL28161986 0.57 — —
SCHEMBL28250292 0.52 — —
SCHEMBL14842617 0.52 — —
SCHEMBL3756700 0.52 — —
SCHEMBL23374074 0.51 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101102818-A Medicaments comprising carbonyl compounds, and the use thereof MERCK PATENT GMBH (DE) 2008-01-09 — — CN disclosed
CN-1771237-A 1- (phenylcarbamoyl) -2- (4- (3-oxo-morpholin-4-yl) -phenylcarbamoyl) pyrrolidine derivatives and related compounds as inhibitors of coagulation factor X A in the treatment of thromboembolic disorders MERCK PATENT GMBH (DE) 2006-05-10 — — CN disclosed
Send feedback